
    
      This study will be divided into 3 timepoints:

        -  Epoch 1- Primary- From day 1 to day 301

        -  Epoch 2-Secondary-From day 301 to day 331

        -  Epoch 3-Safety follow up -From day 331 to study end (day 661) In addition to receiving
           the study vaccines, infants will also receive non-study vaccines such as Diphtheria,
           tetanus toxoids and acellular pertussis adsorbed vaccine (DTPa, Infanrix) and
           Haemophilus influenzae type b Conjugate Vaccine (Hib, Hiberix), to ease the disruption
           to the standard infant vaccine schedule caused by participating in this study.
    
  